• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 432609 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414042928 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414042928 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Cleveland Biolabs, Shares Up 6.2% (CBLI)

Published on Wed, 01/30/2013 - 13:23
By Robert Cotter

Cleveland Biolabs (NASDAQ:CBLI) is one of today's best performing low-priced stocks, up 6.2% to $1.62 on 1.1x average daily volume. Thus far today, Cleveland Biolabs has traded 295,000 shares, vs. average volume of 266,000 shares per day. The stock has outperformed the Dow (6.6% to the Dow's 0.1%) and outperformed the S&P 500 (6.6% to the S&P's -0.0%) during today's trading.

Cleveland Biolabs, Inc. develops pharmaceuticals. The Company develops drugs to protect humans from exposure to radiation.

Cleveland Biolabs share prices have moved between a 52-week high of $4.06 and a 52-week low of $1.15 and are now trading 41% above that low price at $1.62 per share. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.9%.

There is potential upside of 85.2% for shares of Cleveland Biolabs based on a current price of $1.62 and an average consensus analyst price target of $3.00. Cleveland Biolabs shares should encounter resistance at the 200-day moving average (MA) of $1.68 and support at the 50-day MA of $1.43.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Tesoro: 52-Week High Recently Eclipsed (...

Tesoro (NYSE:TSO) traded at a new 52-week high today of $68.26. This new high was reac ...

Travelers Looks to Continue to Trade Abo...

Shares of Travelers (NYSE:TRV) traded at a new 52-week high today of $96.29. This new ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded at a new 52-week high today of $19.25. Approximately 2.3 ...

Recent 52-Week High Exceeded in Shares o...

STERIS (NYSE:STE) traded at a new 52-week high today of $58.58. So far today approxima ...

Sovran Self Storage: The Winning Streak ...

Sovran Self Storage (NYSE:SSS) traded at a new 52-week high today of $82.00. So far to ...

Sonic: 52-Week High Recently Eclipsed (S...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.89. Approximately 1.2 mi ...

Snap-On Looks to Continue to Trade Above...

Snap-On (NYSE:SNA) traded at a new 52-week high today of $128.65. Approximately 354,00 ...

Super Micro Computer: The Winning Streak...

Shares of Super Micro Computer (NASDAQ:SMCI) traded at a new 52-week high today of $30. ...